|
|
Blood, Vol. 107, Issue 12, 4926-4929, June 15, 2006
Primary cutaneous follicle center lymphoma and primary cutaneous large B-cell lymphoma, leg type, are both targeted by aberrant somatic hypermutation but demonstrate differential expression of AID
Blood Dijkman et al.
107: 4926
Supplemental materials for: Dijkman et al
Files in this Data Supplement:
- Table S1. Mutation patterns of the BCL6, PAX-5, RhoH/TTF and c-MYC genes (PDF, 21.3 KB) -
del/ins indicates number of deletions and insertions; A, T, G or C are mutations occurring at adenosine, thymidine, guanine or cytosine positions; TS, transitions; TV, transversions; DGYW/WRCH, number of mutations embedded in the AID mutational hot spot motive (D = A, G, T; Y = C, T; W = A, T; R = A, G; H = T, C, A); and Total(%), is the sum of mutations in the respective column.
- Table S2. Mutation frequencies in PCLBCL, legtype and PCFCL (PDF, 14 KB) -
*Mutation frequencies were calculated on the entire region analyzed and on mutated cases only, considering 2 alleles/gene/case.
- Table S3. Distribution of mutations in PCLBCL, leg type and PCFCL (PDF, 13.5 KB) -
Number and percentage of patients with BCL-6, PAX-5, RhoH/TTF and c-MYC mutations in primary cutaneous large B-cell lymphoma of the leg (PCLBCL, leg type) and primary cutaneous follicle center lymphoma (PCFCL).
| |
